SCN5A and breast carcinoma: Nav1.5 is also upregulated in breast cancers at the protein level [11, 12], predominantly in its neonatal D1:S3 splice form [13]; however, the sample sizes of these studies were too small to reliably determine the relationship between Nav1.5 expression and clinical outcome.